May 27, 2022 04:12 PM IST

AstraZeneca Standalone March 2022 Net Sales at Rs 231.96 crore, up 10.32% Y-o-Y

AstraZeneca's COVID jab Vaxzevria wins EU approval as booster

"Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine."

COVID vaccine maker AstraZeneca sees profit slump

Profit after tax slumped to $386 million (366 million euros), AstraZeneca said in a statement.

World's biggest vaccine maker Serum halts production with 200 million doses spare

The Serum Institute has produced more than one billion doses of Covishield -- its version of the AstraZeneca jab -- and is a major supplier to the Covax global inoculation programme for poorer countries.

Europe begins reviewing application for AstraZeneca COVID drug

Infections from COVID-19 are still rising in parts of the world including Europe.

COVID vaccine maker AstraZeneca says 2021 profit dives

Profit after tax slumped to just $112 million (98 million euros) compared with $3.2 billion in 2020, the pharmaceutical company said in a statement.

AstraZeneca Standalone December 2021 Net Sales at Rs 200.53 crore, up 0.14% Y-o-Y

AstraZeneca China summoned over suspected fraud

The regulator of the state medical insurance fund said authorities ordered the arrest of all suspects, but did not give details of the suspected violations or the size of funds involved.

AstraZeneca says early trial data indicates third dose helps against Omicron

The increased response, also against the Delta variant, was seen in a blood analysis of people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, the drugmaker said, adding that it would submit this data to regulators worldwide given the urgent need for boosters.

What is marketing authorisation that Covishield has applied for?

AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study

The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.

AstraZeneca Covid vaccine protection wanes after three months: Lancet study

The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with AstraZeneca, known as Covishield in India.

USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca

The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.

Trigger of rare blood clots linked with AstraZeneca Covid vaccine found

An international team of researchers investigated vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis with thrombocytopenia syndrome (TTS), a life-threatening condition seen in a very small number of people after receiving the adenovirus vaccines.

AstraZeneca says it will start profiting from its COVID-19 vaccine

To a far greater extent than the vaccines from Pfizer-BioNTech and Moderna, AstraZeneca’s vaccine has been the workhorse of the effort to vaccinate poorer countries, many of which are facing severe vaccine shortages. About 1.1 billion AstraZeneca doses had reached low- and lower-middle income countries as of around the end of October

AstraZeneca Standalone September 2021 Net Sales at Rs 197.71 crore, down 5.62% Y-o-Y

Pfizer, AstraZeneca COVID vaccines generate more antibodies than natural infection: Study

A team led by researchers at the University of Montreal in Canada found that these antibodies were also effective against the Delta variant.

AstraZeneca sets up clinical data insights division in India

The Bengaluru-based clinical data and insights (CDI) division is a critical advancement to support a growing global portfolio and build on internal data expertise, the drug firm said in a statement.

WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Mansukh Mandaviya

Health Minister Mansukh Mandaviya had also tweeted that he had a detailed interaction with the WHO chief, accompanied by other senior officials of the global health agency on various issues related to health, including pandemic management and WHO reforms.

AstraZeneca joins hands with RGCI to treat leukaemia patients

As part of the programme, the drug maker aims to help identify and support CLL reference laboratories (CRLs) in strategic locations across India and connect peripheral hospitals with them.

Valneva jumps on positive results for COVID-19 vaccine candidate

Valneva is among a handful of vaccine developers testing their vaccines against one already approved by a regulator, rather than giving volunteers a placebo as shots become more available.

AstraZeneca seeks US authorisation of drug to prevent COVID-19

The company has included data from a late-stage trial of more than 5,000 participants that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77 per cent.

India likely to allow smaller gap between two doses of Covishield sold privately: Report

Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and 16 weeks currently, sources said.

SII on track to deliver 200 million doses of Covishield per month: Adar Poonawalla

The SII CEO's statement comes amid the row over the UK tightening quarantine rules for vaccinated Indians. As per the UK government's order, fully vaccinated persons arriving from a number of countries, including India, would be treated as "unvaccinated" and will have to undergo a mandatory 10-day quarantine.